Literature DB >> 29307358

Brain metastases: epidemiology.

Quinn T Ostrom1, Christina Huang Wright2, Jill S Barnholtz-Sloan3.   

Abstract

Brain metastases (BM) are the most commonly diagnosed type of central nervous system tumor in the United States. Estimates of the frequency of BM vary significantly, as there is no nationwide reporting system for metastases. BM may be the first sign of a previously undiagnosed cancer, or occur years or decades after the primary cancer was diagnosed. Incidence of BM varies significantly by primary cancer site. Lung, breast, and melanoma continue to be the leading cause of BM. These tumors are increasingly more common as new therapeutics, advanced imaging, and improved screening have led to lengthened survival after primary diagnosis for cancer patients. BM are difficult to treat, and for most individuals the diagnosis of BM generally portends a poor prognosis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  brain metastases; epidemiology; incidence; survival

Mesh:

Year:  2018        PMID: 29307358     DOI: 10.1016/B978-0-12-811161-1.00002-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  68 in total

Review 1.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

2.  Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.

Authors:  Nooshin Hashemi-Sadraei; Gaëlle M Müller-Greven; Fadi W Abdul-Karim; Ilya Ulasov; Erinn Downs-Kelly; Monica E Burgett; Adam Lauko; Maha A Qadan; Robert J Weil; Manmeet S Ahluwalia; Lingling Du; Richard A Prayson; Samuel T Chao; Thomas G Budd; Jill Barnholtz-Sloan; Amy S Nowacki; Ruth A Keri; Candece L Gladson
Journal:  J Neurooncol       Date:  2018-08-09       Impact factor: 4.130

3.  PET imaging in patients with brain metastasis-report of the RANO/PET group.

Authors:  Norbert Galldiks; Karl-Josef Langen; Nathalie L Albert; Marc Chamberlain; Riccardo Soffietti; Michelle M Kim; Ian Law; Emilie Le Rhun; Susan Chang; Julian Schwarting; Stephanie E Combs; Matthias Preusser; Peter Forsyth; Whitney Pope; Michael Weller; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

Review 4.  A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place.

Authors:  Dawn Swan; David Julian Seiffge; Jecko Thachil
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

5.  Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?

Authors:  Katarzyna Holub; Guillaume Louvel
Journal:  J Neurooncol       Date:  2021-02-15       Impact factor: 4.130

6.  Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Authors:  Mustafa S Ascha; Quinn T Ostrom; James Wright; Priya Kumthekar; Jeremy S Bordeaux; Andrew E Sloan; Fredrick R Schumacher; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05       Impact factor: 4.254

7.  Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.

Authors:  Desmond A Brown; Victor M Lu; Benjamin T Himes; Terry C Burns; Alfredo Quiñones-Hinojosa; Kaisorn L Chaichana; Ian F Parney
Journal:  Clin Exp Metastasis       Date:  2020-01-16       Impact factor: 5.150

8.  Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition.

Authors:  Bryan Ngo; Eugenie Kim; Victoria Osorio-Vasquez; Sophia Doll; Sophia Bustraan; Roger J Liang; Alba Luengo; Shawn M Davidson; Ahmed Ali; Gino B Ferraro; Grant M Fischer; Roozbeh Eskandari; Diane S Kang; Jing Ni; Ariana Plasger; Vinagolu K Rajasekhar; Edward R Kastenhuber; Sarah Bacha; Roshan K Sriram; Benjamin D Stein; Samuel F Bakhoum; Matija Snuderl; Paolo Cotzia; John H Healey; Nello Mainolfi; Vipin Suri; Adam Friedman; Mark Manfredi; David M Sabatini; Drew R Jones; Min Yu; Jean J Zhao; Rakesh K Jain; Kayvan R Keshari; Michael A Davies; Matthew G Vander Heiden; Eva Hernando; Matthias Mann; Lewis C Cantley; Michael E Pacold
Journal:  Cancer Discov       Date:  2020-06-22       Impact factor: 39.397

9.  Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging.

Authors:  Jennifer A Geisler; Jonathan M Spehar; Sarah A Steck; Anna Bratasz; Reena Shakya; Kimerly Powell; Gina M Sizemore
Journal:  J Vis Exp       Date:  2020-06-07       Impact factor: 1.355

10.  Three-dimensional U-Net Convolutional Neural Network for Detection and Segmentation of Intracranial Metastases.

Authors:  Jeffrey D Rudie; David A Weiss; John B Colby; Andreas M Rauschecker; Benjamin Laguna; Steve Braunstein; Leo P Sugrue; Christopher P Hess; Javier E Villanueva-Meyer
Journal:  Radiol Artif Intell       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.